Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Blood

• Publication date

  2008-08-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2008-03-148072PMID 18519810PMCID PMC2515117
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MHC class II antigen loading compartments continuously receive input from autophagosomes

  2008cited by this paper
• DEC‐205/CD205+ dendritic cells are abundant in the white pulp of the human spleen, including the border region between the red and white pulp

  2008cited by this paper
• CD4 and CD8 T cell responses to tumour-associated Epstein–Barr virus antigens in nasopharyngeal carcinoma patients

  2008cited by this paper
• Functional Inactivation of EBV-Specific T-Lymphocytes in Nasopharyngeal Carcinoma: Implications for Tumor Immunotherapy

  2007cited by this paper
• Hematopoietic stem cell–engrafted NOD/SCID/IL2Rγnull mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses

  2007cited by this paper
• Taking dendritic cells into medicine

  2007cited by this paper
• Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting

  2007cited by this paper
• Human-hemato-lymphoid-system mice: opportunities and challenges.

  2007cited by this paper
• Humanized NOD/LtSz‐scid IL2 Receptor Common Gamma Chain Knockout Mice in Diabetes Research

  2007cited by this paper
• HIV Patients Developing Primary CNS Lymphoma Lack EBV-Specific CD4+ T Cell Function Irrespective of Absolute CD4+ T Cell Counts

  2007cited by this paper
• Humanized mice in translational biomedical research

  2007cited by this paper
• Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

  2007cited by this paper
• Phase I/II studies to evaluate safety and immunogenicity of a recombinant gp350 Epstein-Barr virus vaccine in healthy adults.

  2007cited by this paper
• DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes

  2007cited by this paper
• Dendritic cells prime natural killer cells by trans-presenting interleukin 15.

  2007cited by this paper
• Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice.

  2007cited by this paper
• Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes.

  2007cited by this paper
• Hematopoietic stem cell-engrafted NOD/SCID/IL2Rgamma null mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses.

  2007cited by this paper
• Differential Antigen Processing by Dendritic Cell Subsets in Vivo

  2007cited by this paper
• QUASI analysis of the HIV-1 envelope sequences in the Los Alamos National Laboratory HIV sequence database: pattern and distribution of positive selection sites and their frequencies over years.

  2007cited by this paper
• Phase I Trial of a CD8+ T-Cell Peptide Epitope-Based Vaccine for Infectious Mononucleosis

  2007cited by this paper
• Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers.

  2007cited by this paper
• Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults.

  2007cited by this paper
• In vitro anti-tumor immune response induced by dendritic cells transfected with EBV-LMP2 recombinant adenovirus.

  2006cited by this paper
• Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses

  2006cited by this paper
• Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1

  2006cited by this paper
• Functional Reversion of Antigen-Specific CD8+ T Cells from Patients with Hodgkin Lymphoma following In Vitro Stimulation with Recombinant Polyepitope1

  2006cited by this paper
• Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins

  2006cited by this paper
• Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine

  2006cited by this paper
• Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysis

  2006cited by this paper
• Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells.

  2006cited by this paper
• Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2−/−γc−/− mice

  2006cited by this paper
• Human Immunodeficiency Virus Type 1 Pathobiology Studied in Humanized BALB/c-Rag2−/−γc−/− Mice

  2006cited by this paper
• Disseminated and Sustained HIV-Infection in CD34+ Cord Blood Cell Transplanted Rag2−/−gc−/− Mice.

  2006cited by this paper
• Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells.

  2005cited by this paper
• Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice

  2005cited by this paper
• Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

  2005cited by this paper
• Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma.

  2005cited by this paper
• Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells.

  2005cited by this paper
• In Vivo Targeting of Antigens to Maturing Dendritic Cells via the DEC-205 Receptor Improves T Cell Vaccination

  2004cited by this paper
• Dual Stimulation of Epstein-Barr Virus (EBV)-Specific CD4+- and CD8+-T-Cell Responses by a Chimeric Antigen Construct: Potential Therapeutic Vaccine for EBV-Positive Nasopharyngeal Carcinoma

  2004cited by this paper
• Endogenous Presentation of CD8+ T Cell Epitopes from Epstein-Barr Virus–encoded Nuclear Antigen 1

  2004cited by this paper
• Induction of Therapeutic T-Cell Responses to Subdominant Tumor-associated Viral Oncogene after Immunization with Replication-incompetent Polyepitope Adenovirus Vaccine

  2004cited by this paper
• Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2Rγnull Mice Engrafted with Mobilized Human Hemopoietic Stem Cells 12

  2004cited by this paper
• Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice

  2004cited by this paper
• CD8 T Cell Recognition of Endogenously Expressed Epstein-Barr Virus Nuclear Antigen 1

  2004cited by this paper
• Epstein-Barr Virus Nuclear Antigen 1

  2004cited by this paper
• Evidence for the Presentation of Major Histocompatibility Complex Class I–restricted Epstein-Barr Virus Nuclear Antigen 1 Peptides to CD8+ T Lymphocytes

  2004cited by this paper
• Multiple Epstein-Barr Virus Infections in Healthy Individuals

  2003cited by this paper
• SIGN-R1, a novel C-type lectin expressed by marginal zone macrophages in spleen, mediates uptake of the polysaccharide dextran.

  2003cited by this paper
• Characteristics of Hodgkin's lymphoma after infectious mononucleosis.

  2003cited by this paper
• Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation

  2003cited by this paper
• Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro

  2003cited by this paper
• Establishment and Maintenance of Gammaherpesvirus Latency Are Independent of Infective Dose and Route of Infection

  2003cited by this paper
• The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen

  2003cited by this paper
• Compartmentalization and Transmission of Multiple Epstein-Barr Virus Strains in Asymptomatic Carriers

  2003cited by this paper
• Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma.

  2003cited by this paper
• In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens.

  2002cited by this paper
• Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma.

  2002cited by this paper
• Characterization of human blood dendritic cell subsets.

  2002cited by this paper
• Epstein-Barr Nuclear Antigen 1-Specific CD4+ Th1 Cells Kill Burkitt’s Lymphoma Cells1

  2002cited by this paper
• EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function.

  2001cited by this paper
• Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors.

  2001cited by this paper
• A monoclonal antibody to the DEC-205 endocytosis receptor on human dendritic cells.

  2000cited by this paper
• Human Cd4+ T Lymphocytes Consistently Respond to the Latent Epstein-Barr Virus Nuclear Antigen Ebna1

  2000cited by this paper
• The Dendritic Cell Receptor for Endocytosis, Dec-205, Can Recycle and Enhance Antigen Presentation via Major Histocompatibility Complex Class II–Positive Lysosomal Compartments

  2000cited by this paper
• Epstein-Barr virus and its replication

  1996cited by this paper
• Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.

  1987cited by this paper
• Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.

  1986cited by this paper
• Pharmacologic effects of polyinosinic• polycytidylic acid in man

  1977cited by this paper

• Designing multifunctional recombinant vaccines: an engineering strategy based on innovative epitope prediction-guided splicing

  2025cites this paper
• Single‐Cell Dissection Reveals Immune Dysregulation After CD5 or CD7‐Directed Chimeric Antigen Receptor T‐Cell Therapy

  2025cites this paper
• Epstein–Barr virus pathogenesis and emerging control strategies

  2025cites this paper
• EBV Infection and Its Immune Control in Humanized Mice.

  2025cites this paper
• Research landmarks on the 60th anniversary of Epstein-Barr virus

  2024cites this paper
• Altered EBV specific immune control in multiple sclerosis.

  2024cites this paper
• GB and gH/gL fusion machinery: a promising target for vaccines to prevent Epstein-Barr virus infection

  2024cites this paper
• Cross-presentation by the others.

  2023cites this paper
• T cell-mediated immunity during Epstein-Barr virus infections in children.

  2023cites this paper
• Targeting dendritic cells to advance cross-presentation and vaccination outcomes.

  2023cites this paper
• Antigen targeting to dendritic cells: Still a place in future immunotherapy?

  2022cites this paper
• A statistical approach to boost soluble expression of E. coli-derived virus-like particles in shake-flask cultivation.

  2022cites this paper
• Immune Response to Viruses

  2022cites this paper
• Applications of Antibody-Based Antigen Delivery Targeted to Dendritic Cells In Vivo

  2022cites this paper
• Urgency and necessity of Epstein-Barr virus prophylactic vaccines

  2022cites this paper
• Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer

  2021cites this paper
• Targeted delivery of a vaccine protein to Langerhans cells in the human skin via the C‐type lectin receptor Langerin

  2021cites this paper
• Lymphoma in Partial DiGeorge Syndrome: Report of 2 Cases.

  2021cites this paper
• Targeted Delivery of BZLF1 to DEC205 Drives EBV-Protective Immunity in a Spontaneous Model of EBV-Driven Lymphoproliferative Disease

  2021cites this paper
• Co-Stimulatory Molecules during Immune Control of Epstein Barr Virus Infection

  2021cites this paper
• The Role of Lytic Infection for Lymphomagenesis of Human γ-Herpesviruses

  2021cites this paper
• Modification of EBV Associated Lymphomagenesis and Its Immune Control by Co-Infections and Genetics in Humanized Mice

  2021cites this paper
• miRNAs: EBV Mechanism for Escaping Host’s Immune Response and Supporting Tumorigenesis

  2020cites this paper
• Vaccination against the Epstein–Barr virus

  2020cites this paper
• Modeling oncogenic herpesvirus infections in humanized mice.

  2020cites this paper
• Probing Reconstituted Human Immune Systems in Mice With Oncogenic γ-Herpesvirus Infections

  2020cites this paper
• Intradermal Delivery of Dendritic Cell-Targeting Chimeric mAbs Genetically Fused to Type 2 Dengue Virus Nonstructural Protein 1

  2020cites this paper
• Targeting Antigens to Different Receptors on Conventional Type 1 Dendritic Cells Impacts the Immune Response

  2020cites this paper
• Cytotoxicity in Epstein Barr virus specific immune control.

  2020cites this paper
• University of Birmingham Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas

  2019cites this paper
• Progress in EBV Vaccines

  2019cites this paper
• Heterologous prime-boost vaccination protects from EBV antigen expressing lymphomas.

  2019influential citation
• Immune Control and Vaccination against the Epstein–Barr Virus in Humanized Mice

  2019influential citation
• The Role of Dendritic Cells in Immune Control and Vaccination against γ-Herpesviruses

  2019cites this paper
• T Cell Antifungal Immunity and the Role of C-Type Lectin Receptors

  2019cites this paper
• Construction of Epstein-Bar virus cocktail peptide fused with Fcγ of IgG: as a potential delivery system for vaccine development

  2019cites this paper
• Advancing immunomodulation by in vivo antigen delivery to DEC-205 and other cell surface molecules using recombinant chimeric antibodies.

  2019cites this paper
• Poly(I:C) Potentiates T Cell Immunity to a Dendritic Cell Targeted HIV-Multiepitope Vaccine

  2019cites this paper
• Targeting M2e to DEC-205 induces an enhanced serum antibody-dependent heterosubtypic protection against influenza A virus infection.

  2019cites this paper
• Infection and immune control of human oncogenic γ-herpesviruses in humanized mice

  2019cites this paper
• Immunogenic particles with a broad antigenic spectrum stimulate cytolytic T cells and offer increased protection against EBV infection ex vivo and in mice

  2018cites this paper
• Antigen-armed antibodies against B-cell malignancies

  2018cites this paper
• Directing pathogen-derived proteins to cells responsible for the immune response activation

  2018cites this paper
• Contribution of Epstein–Barr Virus Latent Proteins to the Pathogenesis of Classical Hodgkin Lymphoma

  2018cites this paper
• Antibodies conjugated with viral antigens elicit a cytotoxic T cell response against primary CLL ex vivo

  2018cites this paper
• Epstein-Barr virus-encoded microRNAs as regulators in host immune responses

  2018cites this paper
• C-Type Lectin Receptors in Antiviral Immunity and Viral Escape

  2018cites this paper
• Dendritic Cell Targeting Effectively Boosts T Cell Responses Elicited by an HIV Multiepitope DNA Vaccine

  2017cites this paper
• Humanised mouse models for haematopoiesis and infectious diseases.

  2017cites this paper
• Dendritic cell targeting vaccine for HPV-associated cancer

  2017cites this paper
• Targeted antigen delivery to dendritic cells elicits robust antiviral T cell-mediated immunity in the liver

  2017cites this paper
• Murine Models of Epstein-Barr Virus-Associated Lymphomagenesis.

  2016cites this paper
• T cell recognition

  2016cites this paper
• Targeting CLEC9A delivers antigen to human CD141+ DC for CD4+ and CD8+T cell recognition.

  2016cites this paper
• Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8+ and CD4+ T Cells

  2016cites this paper
• Effects of Dendritic Cell Subset Manipulation on Airway Allergy in a Mouse Model

  2016cites this paper
• Primary immunodeficiencies associated with EBV-Induced lymphoproliferative disorders.

  2016cites this paper
• Identifying and Targeting Immune Escape Mechanisms in Epstein-Barr Virus-Driven Lymphoproliferative Disease

  2016cites this paper
• Therapeutic HPV Cancer Vaccine Targeted to CD40 Elicits Effective CD8+ T-cell Immunity

  2016cites this paper
• Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies

  2016cites this paper
• Expression and immunogenic characterization of recombinant gp350 for developing a subunit vaccine against Epstein-Barr virus

  2016cites this paper
• Manipulation of antigen presenting cells to enhance host immune responses to bacterial infection

  2015cites this paper
• EBV-Associated Cancer and Autoimmunity: Searching for Therapies

  2015cites this paper
• DNA vaccines encoding DEC205‐targeted antigens: immunity or tolerance?

  2015cites this paper
• Antigen Targeting to Dendritic Cells Allows the Identification of a CD4 T-Cell Epitope within an Immunodominant Trypanosoma cruzi Antigen

  2015cites this paper
• Measurement of CD8+ and CD4+ T Cell Frequencies Specific for EBV LMP1 and LMP2a Using mRNA-Transfected DCs

  2015cites this paper
• Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+ T cells.

  2015cites this paper
• EBV Noncoding RNAs.

  2015cites this paper
• Epstein Barr Virus Volume 2

  2015cites this paper
• The Development of Prophylactic and Therapeutic EBV Vaccines.

  2015cites this paper
• EBV Infection of Mice with Reconstituted Human Immune System Components.

  2015cites this paper
• Dendritic Cell Targeting Vaccines

  2015cites this paper
• LYMPHOID NEOPLASIA Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-speci fi c CD4 1 T cells

  2015cites this paper
• Dendritic cells during Epstein Barr virus infection.

  2014cites this paper
• Epstein–Barr Virus Infection in Humanized Mice

  2014cites this paper
• Adoptive Transfer of EBV Specific CD8+ T Cell Clones Can Transiently Control EBV Infection in Humanized Mice

  2014cites this paper
• Human skin dendritic cells can be targeted in situ by intradermal injection of antibodies against lectin receptors

  2014cites this paper
• Dendritic cells during Epstein Barr virus infection

  2014cites this paper
• Animal models of Epstein Barr virus infection.

  2014cites this paper
• Expression, purification, and immunogenic characterization of Epstein–Barr virus recombinant EBNA1 protein in Pichia pastoris

  2013cites this paper
• Humanized Mouse Models of Epstein-Barr Virus Infection and Associated Diseases

  2013cites this paper
• Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune response.

  2013cites this paper
• Antigen Targeting to Dendritic Cells for Cancer Immunotherapy

  2013cites this paper
• Jianmin after antigen targeting to DEC-205 transformed B cells − Robust T-cell stimulation by Epstein-Barr virus

  2013cites this paper
• Human hemato-lymphoid system mice: current use and future potential for medicine.

  2013cites this paper
• CD141+ dendritic cells produce prominent amounts of IFN-α after dsRNA recognition and can be targeted via DEC-205 in humanized mice.

  2013influential citation
• Etablierung und Charakterisierung von biodegradierbaren Calciumphosphat Nanopartikeln zur Induktion potenter anti-viraler T-Zellantworten

  2013cites this paper
• Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205.

  2013cites this paper
• Die Expression des Chemokinrezeptors XCR1 kennzeichnet kreuzpräsentierende dendritische Zellen der Maus und des Menschen

  2013cites this paper
• Targeting the Non-structural Protein 1 from Dengue Virus to a Dendritic Cell Population Confers Protective Immunity to Lethal Virus Challenge

  2013cites this paper
• Antigen delivery to plasmacytoid dendritic cells -induction of tolerance and immunity.

  2012cites this paper
• Emerging Themes from EBV and KSHV microRNA Targets

  2012cites this paper
• Targeting breast cancer vaccines to dendritic cells: improved immunological responses with less protein?

  2012cites this paper
• Antibody-Antigen-Adjuvant Conjugates Enable Co-Delivery of Antigen and Adjuvant to Dendritic Cells in Cis but Only Have Partial Targeting Specificity

  2012cites this paper
• Targeted antigen delivery to DEC-205⁺ dendritic cells for tolerogenic vaccination.

  2012cites this paper
• EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors.

  2012cites this paper
• Humanized mouse models of infectious diseases

  2012cites this paper
• Direcionando a proteína ASP-2 de formas amastigotas de Trypanosoma cruzi para o receptor DEC205 presente na superfície de células dendríticas.

  2012cites this paper
• Targeting Dendritic Cells in vivo for Cancer Therapy

  2012cites this paper
• Direcionando a proteína ASP-2 de formas amastigotas de Trypanosoma cruzi para o receptor DEC205 presente na superfície de células dendríticas

  2012cites this paper